Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Somalogic Inc (SLGC)
Somalogic Inc (SLGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 449,492
  • Shares Outstanding, K 188,072
  • Annual Sales, $ 97,670 K
  • Annual Income, $ -109,160 K
  • 60-Month Beta 1.67
  • Price/Sales 4.54
  • Price/Cash Flow N/A
  • Price/Book 0.85
Trade SLGC with:

Options Overview Details

View History
  • Implied Volatility 85.18% ( -81.66%)
  • Historical Volatility 34.43%
  • IV Percentile 40%
  • IV Rank 15.53%
  • IV High 448.78% on 10/20/22
  • IV Low 18.34% on 12/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,437
  • Open Int (30-Day) 1,487

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.15
  • Low Estimate -0.21
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +5.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +17.73%
on 08/30/23
2.41 -1.04%
on 09/29/23
+0.32 (+15.46%)
since 08/29/23
3-Month
1.92 +24.16%
on 08/21/23
2.54 -5.91%
on 07/13/23
+0.15 (+6.70%)
since 06/29/23
52-Week
1.92 +24.16%
on 08/21/23
3.79 -36.94%
on 02/02/23
-0.58 (-19.53%)
since 09/29/22

Most Recent Stories

More News
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too

Cathie Wood is loading up on these healthcare stocks.

BEAM : 24.05 (+0.12%)
ARKG : 27.86 (-0.04%)
RXRX : 7.65 (-1.54%)
SLGC : 2.39 (+1.27%)
Why Shares of SomaLogic Are Up Tuesday

The company showed strong revenue growth in the second quarter.

ILMN : 137.28 (+3.72%)
SLGC : 2.39 (+1.27%)
SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe

/PRNewswire/ -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante...

SLGC : 2.39 (+1.27%)
Boxlight Corporation (BOXL) Reports Q1 Loss, Tops Revenue Estimates

Boxlight Corporation (BOXL) delivered earnings and revenue surprises of 20% and 3.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BOXL : 1.9100 (-2.05%)
SLGC : 2.39 (+1.27%)
Duolingo, Inc. (DUOL) Reports Q1 Loss, Tops Revenue Estimates

Duolingo, Inc. (DUOL) delivered earnings and revenue surprises of 75% and 2.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DUOL : 165.87 (+4.23%)
SLGC : 2.39 (+1.27%)
Xperi (ADEA) Beats Q1 Earnings and Revenue Estimates

Xperi (ADEA) delivered earnings and revenue surprises of 41.18% and 17.39%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ADEA : 10.68 (+0.75%)
SLGC : 2.39 (+1.27%)
SomaLogic, Inc. (SLGC) Shareholder Investigation: Robbins LLP is Investigating SomaLogic, Inc. on behalf of Shareholders

Shareholder rights law firm Robbins LLP is investigating SomaLogic, Inc. (NASDAQ: SLGC) to determine whether certain SomaLogic officers and directors violated securities laws and breached fiduciary duties...

SLGC : 2.39 (+1.27%)
Stocks Climb Before the Open as Banking Worries Subside, Alibaba Boosts Sentiment

June S&P 500 futures (ESM23) are up +0.91%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.93% this morning after three major U.S. benchmark indices finished the regular session lower, while U.S....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
AMC : 7.99 (+2.57%)
AMZN : 127.12 (+0.90%)
MKC : 75.64 (+1.33%)
BABA : 86.74 (+1.40%)
UBSG.Z.IX : 22.670 (+0.13%)
IFX.D.DX : 31.350 (-0.08%)
LULU : 385.61 (+1.74%)
NABL : 12.90 (+0.78%)
ARCT : 25.55 (+0.43%)
SLGC : 2.39 (+1.27%)
SomaLogic, Inc. (SLGC) Reports Q4 Loss, Tops Revenue Estimates

SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SLGC : 2.39 (+1.27%)
BRZE : 46.73 (+0.19%)
UiPath (PATH) Q4 Earnings and Revenues Beat Estimates

UiPath (PATH) delivered earnings and revenue surprises of 114.29% and 10.93%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

PATH : 17.11 (+2.03%)
SLGC : 2.39 (+1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 2.51
2nd Resistance Point 2.46
1st Resistance Point 2.43
Last Price 2.39
1st Support Level 2.34
2nd Support Level 2.29
3rd Support Level 2.26

See More

52-Week High 3.79
Fibonacci 61.8% 3.08
Fibonacci 50% 2.86
Fibonacci 38.2% 2.64
Last Price 2.39
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar